OS Therapies (OSTX) Competitors $2.95 -1.17 (-28.40%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends OSTX vs. TERN, AKBA, ABVX, CDXC, KOD, NMRA, ORGO, AURA, KALV, and ETONShould you be buying OS Therapies stock or one of its competitors? The main competitors of OS Therapies include Terns Pharmaceuticals (TERN), Akebia Therapeutics (AKBA), ABIVAX Société Anonyme (ABVX), ChromaDex (CDXC), Kodiak Sciences (KOD), Neumora Therapeutics (NMRA), Organogenesis (ORGO), Aura Biosciences (AURA), KalVista Pharmaceuticals (KALV), and Eton Pharmaceuticals (ETON). These companies are all part of the "pharmaceutical products" industry. OS Therapies vs. Terns Pharmaceuticals Akebia Therapeutics ABIVAX Société Anonyme ChromaDex Kodiak Sciences Neumora Therapeutics Organogenesis Aura Biosciences KalVista Pharmaceuticals Eton Pharmaceuticals OS Therapies (NYSE:OSTX) and Terns Pharmaceuticals (NASDAQ:TERN) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, analyst recommendations, community ranking, dividends, valuation, earnings and profitability. Is OSTX or TERN more profitable? OS Therapies' return on equity of 0.00% beat Terns Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets OS TherapiesN/A N/A -569.57% Terns Pharmaceuticals N/A -32.76%-31.33% Do insiders & institutionals have more ownership in OSTX or TERN? 98.3% of Terns Pharmaceuticals shares are held by institutional investors. 15.1% of Terns Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has higher valuation & earnings, OSTX or TERN? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOS TherapiesN/AN/A-$7.79MN/AN/ATerns PharmaceuticalsN/AN/A-$90.21M-$1.18-3.75 Do analysts prefer OSTX or TERN? OS Therapies presently has a consensus target price of $17.50, indicating a potential upside of 493.22%. Terns Pharmaceuticals has a consensus target price of $18.30, indicating a potential upside of 313.09%. Given OS Therapies' stronger consensus rating and higher possible upside, analysts plainly believe OS Therapies is more favorable than Terns Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OS Therapies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50Terns Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Does the media favor OSTX or TERN? In the previous week, OS Therapies had 19 more articles in the media than Terns Pharmaceuticals. MarketBeat recorded 19 mentions for OS Therapies and 0 mentions for Terns Pharmaceuticals. OS Therapies' average media sentiment score of 0.15 beat Terns Pharmaceuticals' score of 0.00 indicating that OS Therapies is being referred to more favorably in the media. Company Overall Sentiment OS Therapies Neutral Terns Pharmaceuticals Neutral Does the MarketBeat Community prefer OSTX or TERN? Terns Pharmaceuticals received 37 more outperform votes than OS Therapies when rated by MarketBeat users. However, 100.00% of users gave OS Therapies an outperform vote while only 60.87% of users gave Terns Pharmaceuticals an outperform vote. CompanyUnderperformOutperformOS TherapiesOutperform Votes5100.00% Underperform VotesNo VotesTerns PharmaceuticalsOutperform Votes4260.87% Underperform Votes2739.13% SummaryOS Therapies beats Terns Pharmaceuticals on 8 of the 13 factors compared between the two stocks. Get OS Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for OSTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OSTX vs. The Competition Export to ExcelMetricOS TherapiesPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$63.52M$6.21B$5.20B$19.94BDividend YieldN/A2.94%5.13%3.70%P/E RatioN/A9.2687.2540.66Price / SalesN/A309.921,263.9116.25Price / CashN/A61.4443.7719.88Price / BookN/A6.055.315.76Net Income-$7.79M$154.90M$122.54M$993.17M7 Day Performance-29.09%1.35%1.44%2.27%1 Month Performance-25.69%0.41%2.51%4.76%1 Year PerformanceN/A3.08%25.32%18.83% OS Therapies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OSTXOS Therapies2.2342 of 5 stars$2.95-28.4%$17.50+493.2%N/A$63.52MN/A0.00N/ATERNTerns Pharmaceuticals3.8007 of 5 stars$4.74-5.4%$18.30+286.1%-8.8%$402.61M$1M-4.0240AKBAAkebia Therapeutics3.9076 of 5 stars$1.84+5.1%$7.50+307.6%+47.9%$401.45M$169.88M-8.00430Positive NewsABVXABIVAX Société Anonyme2.149 of 5 stars$6.31-1.1%$38.67+512.8%-46.8%$399.73MN/A0.0061CDXCChromaDex4.5734 of 5 stars$5.23-0.8%$8.00+53.0%+324.3%$399.48M$91.67M523.52120Short Interest ↑KODKodiak Sciences3.7109 of 5 stars$7.53-9.5%$8.00+6.2%+129.8%$396.26MN/A-2.0690Short Interest ↑NMRANeumora Therapeutics3.6249 of 5 stars$2.40+8.6%$16.50+587.5%-85.6%$387.75MN/A-1.28108ORGOOrganogenesis4.4461 of 5 stars$2.95-2.0%$5.00+69.5%-10.7%$370.89M$455.04M-49.17950AURAAura Biosciences2.4138 of 5 stars$7.42-2.4%$23.00+210.0%+0.8%$370.64MN/A-4.2950Positive NewsKALVKalVista Pharmaceuticals4.3913 of 5 stars$7.50-4.5%$25.00+233.3%-33.1%$370.64MN/A-2.06150News CoveragePositive NewsETONEton Pharmaceuticals3.3824 of 5 stars$14.08+4.8%$18.67+32.6%+248.1%$366.80M$34.68M-64.0020 Related Companies and Tools Related Companies Terns Pharmaceuticals Competitors Akebia Therapeutics Competitors ABIVAX Société Anonyme Competitors ChromaDex Competitors Kodiak Sciences Competitors Neumora Therapeutics Competitors Organogenesis Competitors Aura Biosciences Competitors KalVista Pharmaceuticals Competitors Eton Pharmaceuticals Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:OSTX) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OS Therapies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share OS Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OSTX Stock Alerts